PAM
GILD icon

PVG Asset Management’s Gilead Sciences GILD Stock Holding History

PVG Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$696K Sell
9,305
-366
-4% -$25.3K 1.64% 15
2019
Q4 		$628K Buy
+9,671
New +$630K 0.88% 31
2019
Q3 		– Sell
-14,367
Closed -$970K – 84
2019
Q2 		$970K Buy
+14,367
New +$945K 1.02% 30
2018
Q4 		– Sell
-2,640
Closed -$203K – 65
2018
Q3 		$203K Buy
+2,640
New +$199K 0.15% 78

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

PVG Asset Management's GILD Position: Q1 2020 in Review

PVG Asset Management reduced its Gilead Sciences (GILD) stake by 3.8% in Q1 2020, selling an estimated $25.3K and leaving 9,305 shares worth $696K. The position accounts for 1.64% of the portfolio, ranked #15.

PVG Asset Management first reported a position in GILD in Q3 2018 and has held it in 4 quarters since. The position peaked at $970K in Q2 2019. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • PVG Asset Management held 9,305 shares of Gilead Sciences worth $696K as of Q1 2020.
  • PVG Asset Management sold 366 Gilead Sciences shares in Q1 2020, an estimated $25.3K.
  • Gilead Sciences made up 1.64% of PVG Asset Management's portfolio in Q1 2020, its #15 holding.
  • PVG Asset Management first reported a position in Gilead Sciences in Q3 2018 and has held it in 4 quarters since.
  • PVG Asset Management's Gilead Sciences position peaked at $970K in Q2 2019.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on PVG Asset Management's 13F filing for Q1 2020, filed 15 May 2020.